Related Experiment Video
Updated: Dec 21, 2025
09:03
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
5.3K
Managing COVID-19 disease in pediatric patients
1Department of Primary Care Pediatrics, Pediatric Institute, Cleveland Clinic yemone@ccf.org.
Cleveland Clinic Journal of Medicine
|May 13, 2020
Summary
Children rarely contract SARS-CoV-2, the virus causing COVID-19, and typically experience milder illness. However, infants and children with health conditions can face severe complications.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Children show lower SARS-CoV-2 infection rates compared to adults.
- COVID-19 in children generally presents with milder symptoms and lower fatality rates.
Purpose of the Study:
- To discuss the unique presentation and disease course of COVID-19 in pediatric populations.
- To explore potential vertical transmission of SARS-CoV-2 from mothers to newborns.
Main Methods:
- Literature review of pediatric COVID-19 cases.
- Analysis of epidemiological data on child infections.
- Review of studies on vertical transmission.
Main Results:
- Children represent 1-8% of diagnosed COVID-19 cases.
- Preschoolers, infants, and those with comorbidities are at higher risk for severe disease.
- COVID-19 presentation and complications in children differ from adults.
Conclusions:
- While generally less affected, certain pediatric groups require close monitoring for severe COVID-19.
- Understanding unique pediatric disease aspects is crucial for management.
- Further research is needed on SARS-CoV-2 vertical transmission.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
148
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
01:24Cystic Fibrosis: Management
373
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
373
01:28Pneumonia IV: Management
664
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
664
01:30Pneumonia V: Nursing management and Prevention
3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:29Drug Dosing: Infants and Children
172
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172